FDA.reportPublic FDA data

alogliptin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Kazano]

RxCUI
1368398
RxNorm name
alogliptin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Kazano]
Display name
alogliptin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Kazano]
Full name
alogliptin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Kazano]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KAZANOALOGLIPTIN AND METFORMIN HYDROCHLORIDETakeda Pharmaceuticals America, Inc.83cb7914-a683-47bb-a713-f2bc6a596bd22026-08-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1368398

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
83cb7914-a683-47bb-a713-f2bc6a596bd2Kazano 12.5 MG / 500 MG Oral Tablet [PSN] · alogliptin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Kazano] [SBD] · Kazano 12.5/500 (as alogliptin benzoate 17 MG / metformin hydrochloride) Oral Tablet [SY] · Kazano 12.5/500 Oral Tablet [SY]421These highlights do not include all the information needed to use KAZANO ® safely and effectively. See full prescribing information for KAZANO. KAZANO (alogliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 201320250530